SLC67A1 and embryonal rhabdomyosarcoma: On the other hand, defective SLC22A18 has been described in lung cancer (LNCR) and other types of tumors, such as embryonal rhabdomyosarcoma 1 (RMSE1) (FDR = 8.09 × 10−4) (Figure 8b).